These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 24465242)

  • 1. Molecular vibration-activity relationship in the agonism of adenosine receptors.
    Chee HK; Oh SJ
    Genomics Inform; 2013 Dec; 11(4):282-8. PubMed ID: 24465242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics in Molecular Vibrational Frequency Patterns between Agonists and Antagonists of Histamine Receptors.
    Oh SJ
    Genomics Inform; 2012 Jun; 10(2):128-32. PubMed ID: 23105941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A structure-odour relationship study using EVA descriptors and hierarchical clustering.
    Takane SY; Mitchell JB
    Org Biomol Chem; 2004 Nov; 2(22):3250-5. PubMed ID: 15534702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristic molecular vibrations of adenosine receptor ligands.
    Chee HK; Yang JS; Joung JG; Zhang BT; Oh SJ
    FEBS Lett; 2015 Feb; 589(4):548-52. PubMed ID: 25622891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrinsic activity at adenosine A1 receptors: partial and inverse agonism.
    de Ligt RA; IJzerman AP
    Curr Pharm Des; 2002; 8(26):2333-44. PubMed ID: 12369948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New paradigms in adenosine receptor pharmacology: allostery, oligomerization and biased agonism.
    Vecchio EA; Baltos JA; Nguyen ATN; Christopoulos A; White PJ; May LT
    Br J Pharmacol; 2018 Nov; 175(21):4036-4046. PubMed ID: 29679502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence that adenosine mediates the depression of spinal dorsal horn neurons induced by peripheral vibration in the cat.
    Salter MW; Henry JL
    Neuroscience; 1987 Aug; 22(2):631-50. PubMed ID: 3670602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutagenesis reveals structure-activity parallels between human A2A adenosine receptors and biogenic amine G protein-coupled receptors.
    Jiang Q; Lee BX; Glashofer M; van Rhee AM; Jacobson KA
    J Med Chem; 1997 Aug; 40(16):2588-95. PubMed ID: 9258366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-based approaches to ligands for G-protein-coupled adenosine and P2Y receptors, from small molecules to nanoconjugates.
    Jacobson KA
    J Med Chem; 2013 May; 56(10):3749-67. PubMed ID: 23597047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New heterocyclic ligands for the adenosine receptors P1 and for the ATP receptors P2.
    Baraldi PG; Romagnoli R; Tabrizi MA; Bovero A; Preti D; Fruttarolo F; Moorman AR; Borea PA
    Farmaco; 2005 Mar; 60(3):185-202. PubMed ID: 15784237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. G protein-coupled adenosine (P1) and P2Y receptors: ligand design and receptor interactions.
    Jacobson KA; Balasubramanian R; Deflorian F; Gao ZG
    Purinergic Signal; 2012 Sep; 8(3):419-36. PubMed ID: 22371149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A1 adenosine receptors and their ligands: overview and recent developments.
    Müller CE
    Farmaco; 2001; 56(1-2):77-80. PubMed ID: 11347971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A(3) adenosine receptor ligands: history and perspectives.
    Baraldi PG; Cacciari B; Romagnoli R; Merighi S; Varani K; Borea PA; Spalluto G
    Med Res Rev; 2000 Mar; 20(2):103-28. PubMed ID: 10723024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring Adenosine Receptor Ligands: Potential Role in the Treatment of Cardiovascular Diseases.
    Geldenhuys WJ; Hanif A; Yun J; Nayeem MA
    Molecules; 2017 Jun; 22(6):. PubMed ID: 28587166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, CoMFA analysis, and receptor docking of 3,5-diacyl-2, 4-dialkylpyridine derivatives as selective A3 adenosine receptor antagonists.
    Li AH; Moro S; Forsyth N; Melman N; Ji XD; Jacobson KA
    J Med Chem; 1999 Feb; 42(4):706-21. PubMed ID: 10052977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure based prediction of subtype-selectivity for adenosine receptor antagonists.
    Katritch V; Kufareva I; Abagyan R
    Neuropharmacology; 2011 Jan; 60(1):108-15. PubMed ID: 20637786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenosine receptors: new opportunities for future drugs.
    Poulsen SA; Quinn RJ
    Bioorg Med Chem; 1998 Jun; 6(6):619-41. PubMed ID: 9681130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-Activity Analysis of Biased Agonism at the Human Adenosine A3 Receptor.
    Baltos JA; Paoletta S; Nguyen AT; Gregory KJ; Tosh DK; Christopoulos A; Jacobson KA; May LT
    Mol Pharmacol; 2016 Jul; 90(1):12-22. PubMed ID: 27136943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biased agonism at G protein-coupled receptors: the promise and the challenges--a medicinal chemistry perspective.
    Shonberg J; Lopez L; Scammells PJ; Christopoulos A; Capuano B; Lane JR
    Med Res Rev; 2014 Nov; 34(6):1286-330. PubMed ID: 24796277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glutamate residues in the second extracellular loop of the human A2a adenosine receptor are required for ligand recognition.
    Kim J; Jiang Q; Glashofer M; Yehle S; Wess J; Jacobson KA
    Mol Pharmacol; 1996 Apr; 49(4):683-91. PubMed ID: 8609897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.